so sites must reevaluate their quality and safety credentials and maintain a state of good manufacturing practice (GMP) readiness. Throughout the pandemic, the lack of FDA inspections has created ...

According to reports, there are more than 8500 small and medium manufacturers with less than Rs 250 crore turnover in the ...

It's marketed as a generic option to name-brand mood meds, but it's been recalled for the same reason a competitor was just ...

Shortly after making an M&A play to break into the CDMO business, Granules’ manufacturing bona fides have come under fire in ...

Symbiosis Pharmaceutical Services has completed the latest inspection by the U.S. FDA of its facilities in Scotland.

Gemini Bioproducts, LLC ("GeminiBio"), a biopharma and advanced therapy raw materials supplier, and a portfolio company of BelHealth Investment Partners, LLC ("BelHealth"), a Fort Lauderdale-based ...

LGM Pharma invests $6 mn in US drug manufacturing facility to increase capacity for liquid, suspension, semi-solid & suppository drug products: Boca Raton, Florida Saturday, March ...

and Manufacturing Organization (CRDMO), today announced that it has again passed the GMP inspection by Japan's Pharmaceuticals and Medical Devices Agency (PMDA) for its drug substance facilities ...

Lonza will leverage its expertise in exosome development and analytical services to define a GMP-compliant process for Exo-101 production.